Cargando…

A new class of bronchodilator improves lung function in COPD: a trial with GSK961081

GSK961081 is a bifunctional molecule demonstrating both muscarinic antagonist and β-agonist activities. This was a 4-week, multicentre, randomised, double-blind, double-dummy, placebo and salmeterol controlled parallel group study. Doses ranging across three twice-daily doses and three once-daily do...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wielders, Pascal L.M.L., Ludwig-Sengpiel, Andrea, Locantore, Nicholas, Baggen, Suus, Chan, Robert, Riley, John H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787816/ https://www.ncbi.nlm.nih.gov/pubmed/23429913 http://dx.doi.org/10.1183/09031936.00165712

Ejemplares similares

Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β(2)-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial
por: Ambery, Claire L., et al.
Publicado: (2015)

Use of Propranolol Blockade to Explore the Pharmacology of GSK961081, a Bi-Functional Bronchodilator, in Healthy Volunteers: Results from Two Randomized Trials
por: Norris, Virginia, et al.
Publicado: (2014)

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients
por: Beier, Jutta, et al.
Publicado: (2012)

Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007)

COPD: maximization of bronchodilation
por: Nardini, Stefano, et al.
Publicado: (2014)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Bronchodilators use in patients with COPD
por: Dong, Yaa-Hui, et al.
Publicado: (2015)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

When is dual bronchodilation indicated in COPD?
por: Thomas, Mike, et al.
Publicado: (2017)

Bronchodilator response of advanced lung function parameters depending on COPD severity
por: Jarenbäck, Linnea, et al.
Publicado: (2016)

Impact of bronchodilator therapy on exercise tolerance in COPD
por: Aguilaniu, B
Publicado: (2010)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Flow and volume response to bronchodilator in patients with COPD
por: Matteo, Vigna, et al.
Publicado: (2018)

Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review
por: Price, David, et al.
Publicado: (2016)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
por: Strange, Charlie, et al.
Publicado: (2019)

Future concepts in bronchodilation for COPD: dual- versus monotherapy
por: Singh, Dave, et al.
Publicado: (2021)

Stepwise management of COPD: What is next after bronchodilation?
por: Miravitlles, Marc, et al.
Publicado: (2023)

Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness
por: Chen, Chunlan, et al.
Publicado: (2016)

Airway wall thickness is increased in COPD patients with bronchodilator responsiveness
por: Kim, Victor, et al.
Publicado: (2014)

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
por: Pascoe, Steven, et al.
Publicado: (2016)

Bronchodilator responsiveness or reversibility in asthma and COPD – a need for clarity
por: Barjaktarevic, Igor, et al.
Publicado: (2018)

Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
por: Voorham, Jaco, et al.
Publicado: (2019)

Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial
por: Ramírez-Venegas, Alejandra, et al.
Publicado: (2019)

Is it Reasonable to Start Bronchodilator Treatment Before Confirming the Diagnosis of COPD?
por: Figueira-Gonçalves, Juan Marco, et al.
Publicado: (2023)

Effect of perioperative bronchodilator therapy on postoperative pulmonary function among lung cancer patients with COPD
por: Shin, Sun Hye, et al.
Publicado: (2021)

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis
por: Huisman, Eline L, et al.
Publicado: (2015)

Therapeutic Success in Swiss COPD Patients Receiving Dual Bronchodilation Therapy as COPD Maintenance Treatment
por: Spielmanns, Marc, et al.
Publicado: (2022)

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
por: Hanania, Nicola A, et al.
Publicado: (2011)

Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality
por: Salpeter, Shelley R
Publicado: (2007)

Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
por: Kang, Jieun, et al.
Publicado: (2017)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
por: Neder, José Alberto, et al.
Publicado: (2019)

Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients
por: Minakata, Yoshiaki, et al.
Publicado: (2020)

Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
por: Gong, Shiyi, et al.
Publicado: (2021)

Acute Effect of Bronchodilator on Intrathoracic Airway Wall Compliance in COPD Patients
por: Pini, Laura, et al.
Publicado: (2022)

ERS Congress highlight: educational forum on continuing professional development
por: Sehlbach, Carolin, et al.
Publicado: (2018)

Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?
por: Scuarcialupi, Maria Enedina Aquino, et al.
Publicado: (2014)

Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
por: Nicolini, Antonello
Publicado: (2012)

Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2013)

Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015)

A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study
por: Juvelekian, Georges, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hr0kvats74lu1t442d0qvilpn7